Table 1.
Demographic characteristics of the patients at baseline.
| Author (Year) | Type of Study | LOE | Study Group | Control Group | Fell at least Once in Past Year | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | Age | Sex | n | Age | Sex | Study | Control | |||
| Ansai et al., (2015) [42] | RCT | I | 23 | 81.9 y | 73.9% F, 26.1% M | 23 | 82.6 y | 65.2% F, 34.8% M | 10 (43.5%) * | 8 (34.8%) * |
| 23 | 82.8 y | 65.2% F, 34.8% M | 7 (30.4%) * | |||||||
| Arkkukangas et al., (2019) [36] | RCT | I | 61 | 83 y | 67% F, 33% M | 56 | 82 y | 73% F, 27% M | 24 (39%) | 21 (37%) |
| Arnold et al., (2010) [34] | RCT | I | 28 | 73.2 y | 71.4% F, 28.6% M | 25 | 75.8 y | 64%F, 36%M | 14 (50%) | 9 (36%) |
| 26 | 74.4 y | 77% F, 23% M | 16 (62%) | |||||||
| Boongird et al., (2017), [37] | RCT | I | 219 | 74.08 y | 83.6% F, 16.4% M | 220 | 73.94 y | 81.4% F, 18.6% M | ||
| Clemson et al., (2010) [46] | RCT | I | 18 | 81 y | 50% F, 50% M | 16 | 82 y | 44% F, 56% M | 7 (39%) † | 4 (25%) † |
| El-Khoury et al., (2015) [39] | RCT | I | 352 | 79.8 y | 100% F | 354 | 79.6 y | 100% F | 137 (39%) | 159 (45%) |
| Gianoudis et al., (2014) [48] | RCT | I | 81 | 67.7 y | 64% F, 36% M | 81 | 67.2 y | 73% F, 27% M | 11 (13.6%) | 10 (12.4%) |
| Hale et al., (2012) [35] | RCT | I | 23 | 73.6 y | 74% F, 26% M | 16 | 75.7 y | 75% F, 25% M | 13 (61%) | 11 (69%) |
| Hewitt et al., (2018) [45] | RCT | I | 113 | 86 y | 62.8% F, 37.2% M | 108 | 86 y | 68.2% F, 31.8% M | 69 (61%) | 54 (50.5%) |
| Jacobson et al., (2011) [43] | RCT | I | 14 | 83.05 y | 57.1% F, 42.9% M | 11 | 81.37 y | 72.7% F, 27.3% M | ||
| Leiros-Rodriíguez et al., (2014) [40] | RCT | I | 14 | 69 y | 100% F | 14 | 68 y | 100% F | ||
| Liu-Ambrose et al., (2019) [38] | RCT | I | 172 | 81.2 y | 64% F, 36% M | 172 | 81.9 y | 69% F, 31% M | 43 (25%) | 60 (35%) |
| Miko et al., (2018) [41] | RCT | I | 50 | 69.33 y | 100% F | 50 | 69.10 y | 100% F | ||
| Patil et al., (2015) [49] | RCT | I | 205 | 74.4 y | 100% F | 204 | 74 y | 100% F | ||
| Patti et al., (2017) [44] | RCT | I | 49 | 67.32 y | 53% F, 47% M | 43 | 68.93 y | 55.8% F, 44.2% M | ||
| Smulders et al., (2010) [47] | RCT | I | 50 | 70.5 y | 90% F, 10% M | 46 | 71.6 y | 97.8% F, 2.2% M | ||
RCT: randomized clinical trial; LOE: levels of evidence; N.: number of participants; y: years; F: female; M: male. * = fall in the past 3 months; † = frequent falls (≥3) in the past 12 months.